Lapatinib for inflammatory breast cancer.
Hall
Peter S
PS
Hanby
Andrew
A
Cameron
David A
DA
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D005260:Female; D018734:Genes, erbB-2 / Q000235:genetics; D006801:Humans; D007249:Inflammation; D000077341:Lapatinib; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077341:Lapatinib